Agios Pharmaceuticals Inc.
AGIO | NASDAQ
$34.32
+$0.37 (+1.09%)
Sep 22, 2026, 10:17 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 44.75M | 20.75M | 19.97M | 12.88M | 12.46M | 8.73M | 10.73M | 8.96M | 8.62M | 8.19M | 7.1M | 7.4M | 6.71M | 5.61M | 4.31M | 3.52M | 5.58M | 832K | n/a | n/a | n/a | n/a |
Cost of Revenue | 3M | 2.68M | 3.15M | 3.05M | 2.96M | 2.36M | 1.26M | 783K | 3.09M | 1.98M | 1.99M | 633K | 5.57M | 4.95M | 4.79M | 5.01M | 5.21M | 5.25M | 4.61M | 4.58M | 4.69M | 4.9M |
Gross Profit | 41.75M | 18.06M | 16.82M | 9.83M | 9.49M | 6.36M | 9.47M | 8.18M | 5.53M | 6.21M | 5.11M | 6.77M | 1.14M | 657K | -480K | -1.5M | 373K | -4.42M | -4.61M | -4.58M | -4.69M | -4.9M |
Operating Income | -110.55M | -110.03M | -121.58M | -116.87M | -127.06M | -106.63M | -125.04M | -102.81M | -105.82M | -92.07M | -106.28M | -100.9M | -93.7M | -90.61M | -99.17M | -91.09M | -97.64M | -101.15M | -104.83M | -91.15M | -91.22M | -91.22M |
Interest Income | 9.73M | 10.8M | 12.41M | 13.37M | 14.51M | 16.09M | 18.02M | 13.06M | 8.12M | 8.89M | 8.62M | 8.38M | 8.25M | 8.09M | 6.49M | 3.82M | 1.79M | 694K | 332K | 256K | n/a | 340K |
Pretax Income | -100.7M | -99.11M | -109.06M | -103.43M | -112.02M | -89.29M | -105.4M | 1B | -96.12M | -81.55M | -95.94M | -91.32M | -83.81M | -81.02M | 36.53M | -81.75M | -91.81M | -94.77M | -98.58M | -84.26M | -82.79M | -90.88M |
Net Income | -100.7M | -99.11M | -108.04M | -103.43M | -112.02M | -89.29M | -96.52M | 947.92M | -96.12M | -81.55M | -95.94M | -91.32M | -83.81M | -81.02M | 36.53M | -81.75M | -91.81M | -94.77M | -94.63M | -88.15M | -83.42M | -118.23M |
Selling & General & Admin | 51.55M | 48.3M | 51.61M | 41.27M | 45.87M | 41.53M | 51.7M | 38.54M | 35.54M | 31.01M | 35.31M | 25.82M | 27.75M | 25.76M | 30.21M | 26.61M | 25.78M | 29.08M | 29.12M | 24.78M | 26.87M | 31.13M |
Research & Development | 100.75M | 79.79M | 86.79M | 85.42M | 90.68M | 71.47M | 82.81M | 72.46M | 75.81M | 67.27M | 76.09M | 81.84M | 67.09M | 65.51M | 68.48M | 62.99M | 72.23M | 67.65M | 71.1M | 61.79M | 59.66M | 55.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 152.3M | 128.09M | 138.4M | 126.7M | 136.55M | 112.99M | 134.51M | 110.99M | 111.34M | 98.29M | 111.39M | 107.66M | 94.84M | 91.27M | 98.69M | 89.6M | 98.01M | 96.72M | 100.22M | 86.57M | 86.53M | 86.32M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 92K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 155.3M | 130.77M | 141.55M | 129.75M | 139.51M | 115.36M | 135.77M | 111.78M | 114.43M | 100.26M | 113.38M | 108.3M | 100.41M | 96.22M | 103.48M | 94.61M | 103.22M | 101.98M | 104.83M | 91.15M | 91.22M | 91.22M |
Income Tax Expense | n/a | n/a | -1.02M | n/a | n/a | n/a | -8.88M | 53.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 59.49M | 58.78M | 58.33M | 58.14M | 57.93M | 57.46M | 57.16M | 56.94M | 56.8M | 56.38M | 55.9M | 55.8M | 55.5M | 55.11M | 54.79M | 54.84M | 54.8M | 54.47M | 54.34M | 57.05M | 61.07M | 69.54M |
Shares Outstanding (Diluted) | 59.49M | 58.78M | 58.33M | 58.14M | 57.93M | 57.46M | 57.16M | 58.43M | 56.8M | 56.38M | 55.9M | 55.8M | 55.6M | 55.27M | 54.79M | 54.84M | 54.8M | 54.56M | 54.34M | 57.05M | 61.07M | 69.54M |
EPS (Basic) | -1.69 | -1.69 | -1.85 | -1.78 | -1.93 | -1.55 | -1.69 | 16.65 | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 | -1.30 | 3.14 | -1.32 | -1.68 | -1.62 | -1.74 | -1.56 | -1.41 | -1.70 |
EPS (Diluted) | -1.69 | -1.69 | -1.85 | -1.78 | -1.93 | -1.55 | -1.69 | 16.22 | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 | -1.29 | 3.14 | -1.32 | -1.68 | -1.62 | -1.74 | -1.56 | -1.41 | -1.70 |
EBITDA | -109.2M | -97.75M | -107.79M | -102.06M | -110.76M | -88.01M | -104.03M | 1B | -94.53M | -80.2M | -94.54M | -89.7M | -79.34M | -76.62M | 40.9M | -77.25M | -87.03M | -89.86M | -93.97M | -79.68M | -78.01M | -85.98M |
EBIT | -110.55M | -99.11M | -109.06M | -103.43M | -112.02M | -89.29M | -105.4M | 1B | -96.12M | -81.55M | -95.94M | -91.32M | -83.81M | -81.02M | 36.53M | -81.75M | -91.81M | -94.77M | -98.58M | -84.26M | -82.7M | -90.88M |
Depreciation & Amortization | 1.35M | 1.36M | 1.27M | 1.37M | 1.26M | 1.28M | 1.37M | 1.35M | 1.59M | 1.35M | 1.4M | 1.62M | 4.46M | 4.4M | 4.38M | 4.49M | 4.77M | 4.91M | 4.61M | 4.58M | 4.69M | 4.9M |
Add to Watchlist
Select watchlists to add or remove AGIO